Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients

被引:0
|
作者
Dorflinger, Charles [1 ]
LeHew, Colleen [1 ]
Carey, Heather [1 ]
Roche-Desilets, Jennifer [1 ]
Burant, Christopher J. [2 ,3 ]
机构
[1] VA Northeast Ohio Healthcare Syst, Pharm Dept, 10701 East Blvd, Cleveland, OH 44106 USA
[2] VA Northeast Ohio Healthcare Syst, Geriatr Res Educ & Clin Ctr, 10701 East Blvd, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA
关键词
MEDICATION ADHERENCE; SCHIZOPHRENIA; PREVALENCE;
D O I
10.1016/j.comppsych.2021.152269
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Effectiveness of long-acting paliperidone palmitate in borderline personality disorder
    Palomares, Nerea
    Montes, Ana
    Diaz-Marsa, Marina
    Carrasco, Jose L.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 338 - 341
  • [2] Effectiveness and Predictors of Continuation of Paliperidone Palmitate Long-Acting Injection Treatment A 12-Month Naturalistic Cohort Study
    Whale, Richard
    Pereira, Marco
    Cuthbert, Sharon
    Fialho, Renata
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (05) : 591 - 595
  • [3] Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection
    Mesones-Peral, Jesus E.
    Gurillo-Munoz, Pedro
    Paz Sanchez-Sicilia, Mari
    Miller, Adam
    Grinant-Fernandez, Alejandra
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 33 - 37
  • [4] Effectiveness of paliperidone long-acting injection in clinical practice
    Deslandes, Paul Nicholas
    Ward, Elan Haf
    Norris, Kathryn
    Sewell, Robert David
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (05) : 139 - 145
  • [5] Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
    Yoshiteru Takekita
    Yosuke Koshikawa
    Chiara Fabbri
    Shiho Sakai
    Naotaka Sunada
    Ai Onohara
    Keiichiro Nishida
    Masafumi Yoshimura
    Masaki Kato
    Alessandro Serretti
    Toshihiko Kinoshita
    BMC Psychiatry, 16
  • [6] Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
    Takekita, Yoshiteru
    Koshikawa, Yosuke
    Fabbri, Chiara
    Sakai, Shiho
    Sunada, Naotaka
    Onohara, Ai
    Nishida, Keiichiro
    Yoshimura, Masafumi
    Kato, Masaki
    Serretti, Alessandro
    Kinoshita, Toshihiko
    BMC PSYCHIATRY, 2016, 16
  • [7] An Assessment of Injection Site Reactions and Injection Site Pain of Once-Every One Month and Three-Month Long-Acting Injectable Formulations of Paliperidone Palmitate
    Elefant, Erica
    Sliwa, Jennifer Kern
    Savitz, Adam
    Nuamah, Isaac
    Mathews, Maju
    Gopal, Srihari
    Najarian, Dean
    Alphs, Larry
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 190 - 190
  • [8] Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate
    Cordiner, Matthew
    Shajahan, Polash
    McAvoy, Sarah
    Bashir, Muhammad
    Taylor, Mark
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2016, 6 (01) : 22 - 32
  • [9] An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate
    Sliwa, Jennifer Kern
    Savitz, Adam
    Nuamah, Isaac
    Mathews, Maju
    Gopal, Srihari
    Elefant, Erica
    Najarian, Dean
    Alphs, Larry
    PERSPECTIVES IN PSYCHIATRIC CARE, 2018, 54 (04) : 530 - 538
  • [10] A case report of pregnancy and paliperidone palmitate 3-monthly long-acting injection
    de Azevedo Avelar, Rita
    Luengo Corbal, Antonio
    Heitor, Maria Joao
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2592 - 2594